FierceBiotech16h
Allogene links off-the-shelf CAR-T to responses and 3 deaths in phase 1 solid tumor trial
Allogene Therapeutics has reported phase 1 data on its solid tumor CAR-T, linking the off-the-shelf cell therapy candidate to ...
Cure Today10d
CAR-T Cell Therapy Receives FDA Designation in Kidney Cancer Subset
Regenerative Medicine Advanced Therapy designation was granted to an investigational CAR-T cell therapy for some patients with renal cell carcinoma. The Food and Drug Administration (FDA) granted ...